Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2005-03-29
2005-03-29
Swartz, Rodney P (Department: 1645)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C424S234100, C424S262100, C435S069100, C435S071100, C530S350000, C536S022100, C536S023700
Reexamination Certificate
active
06872550
ABSTRACT:
A novel approach to Borrelia vaccine formulation taking into account serological, genotypic and epidemiological information by which OspC proteins from different strains ofB. burgdorferiare grouped together. OspC antigens are chosen in order to constitute a representative sample of such groupings, so that the resulting vaccine provides the greatest cross-protectivity with the fewest number of antigens.
REFERENCES:
patent: 4601903 (1986-07-01), Frasch
patent: 4603112 (1986-07-01), Paoletti et al.
patent: 4767622 (1988-08-01), Ristic et al.
patent: 5530103 (1996-06-01), Livey et al.
patent: 5620862 (1997-04-01), Padula et al.
patent: 3942728 (1991-05-01), None
patent: 0 418 827 (1991-03-01), None
patent: 522560 (1993-01-01), None
patent: 9109870 (1991-07-01), None
patent: 9109870 (1991-07-01), None
Stevenson. GenEmbl Database Results. PID: g434658. Submitted Dec. 09, 1993. [Retrieved on Dec. 09, 1999].*
1993.*
Stevenson et al. Injection and Immunity 62(8):3568-3571, 1994 (Aug.).*
Padula et al. Injection and Immunity 61(12): 5097-5105, 1993 (Dec.).*
Anderson et al. Journal of Clinical Microbiology 28(12):2693-2699, 1990 (Dec.).*
Fung et al. Injection and Immunity 62(8): 3213-3221, 1994 (Aug.).*
Sequence Search of 5620862 OSPC 2 pages, Run date Mar. 1996.*
Livey et al Poster #370 at the Vth International Conf. onLyme borreliosisJun. 1992.*
Brockinstedt et al Journal of Immunology 151:900-906, 1993.*
Kantor, Scientific American, Sep. 1994, pp. 34-39 Disarming Lyme Disease.*
Wilske et al World Journal of Microbiology Technology 157:130-136, 1991.*
Fuchs et al. Mol. Microbiology 6:503-509, 1992.*
Wilske et al Annals of New York Academy of Sciences 539: 126-143, 1988.*
Preac-Mursic et al Infection 20:342-349 1992.*
Javris-Heipke et al Med. Microbiol. Immunol. 182:37-50, 1993.*
Wilske et al Infection & Immunity 61:2182-2191, 1993.*
Berzofsky, “Intrinsic and Extrinsic Factors in Protein Antigenic Structure”, Science, vol. 29, Sep. 6, 1985, pp. 932-940.
Young et al., “Efficient Isolation of Genes by Using Antibody Probes”, Proc. Natl. Acad. Sci. USA vol. 80, 1963, pp. 1194-1198.
Hopp et al., “Prediction of Protein Antigenic Determinants from Amino Acid Sequences”, Proc. Natl. Acad. Sci. USA, vol. 78, 1981, pp. 3824-3828.
Wilske, “Immunodominant Borrelia Proteins for the Humoral Immune Response in Lyme Borreliosis”, IV International Conference on Lyme Borreliosis, M/TU-P-38, Jun. 18-21, 1990, p. 82.
Fuchs et al., “Molecular Analysis and Expression of aBorrelia burgdorferiGene Encoding a 22 kDa Protein (pC) inEscherichia coli,”, Molecular Microbiology, 6(4): 503-509 (1992).
Simon et al., “Recombinant Outer Surface Protein A fromBorrelia burgdorferiInduces Antibodies Protective Against Spirochetal Infection in Mice”,The Journal of Infectious Disease, vol. 164, No. 1, 123-32 (1991).
Edelman, “Perspective on the Development of Vaccines Against Lyme Disease”, Vaccine, vol. 9, Aug. 1991, pp. 531-532.
Fikrig et al., “Borrelia burgdorferiStrain 25015: characterization of Outer Surface Protein A and Vaccination Against Infection”, The Journal of Immunology, 148(7): 2256-2260 (Apr. 1992).
Wilske et al., “Detection of IgM- and IgG Antibodies toBorrelia burgdorferiUsing Different Strains as Antigen” Stanek (Ed.), Lyme Borreliosis II, Zbl. Bakt. Suppl. 18, pp. 299-309.
Morgan et al., “Approaches to the Discovery of Non-Peptide Ligands for Peptide Receptors and Peptidases”, Annual Reports in Medicinal Chemistry, Chapter 26, pp. 243-252, 1989.
Laemmli, “Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4”, Nature, vol. 227, Aug. 1970, pp. 680-685.
Wilbur et al., “Rapid Similarity Searches of Nucleic Acid and Protein Data Banks”, Proc. Natl. Acad. Sci. USA, vol. 80, pp. 726-730, Feb. 1983.
Baess, “Isolation and Purification of Deoxyribonucleic Acid From Mycobacteria”, Acta Path. Microbiol. Scand., Sect. B, 82: 780-784, 1974.
Kohler, et al., “Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity”, Nature, vol. 256, Aug. 1975, pp. 495-497.
Peter et al., “Polymorphism of Outer Surface Proteins ofBorrelia burgdorferias a Tool for Classification”, Zbl. Bakjt., 277, pp. 28-33 (1992).
R. Anand, “Pulsed Field Gell Electrophoresis: a technique for fractionating large DNA molecules”, Trends In Genetics, Nov. 1986, pp. 278-283.
Yang et al., “Nucleotide Sequence of the Amylase Gene fromBacillus subtilis” Nucleic Acids Research, vol. 11, No. 2, 1983, pp. 237-249.
Ulmanen et al., “Transcription and Translation of Foreign Genes inBacillus subtilisby the Aid of a Secretion Vector”, Journal of Bacteriology, vol. 162, No. 1, Apr. 1985, pp. 176-182.
Finberg et al., “The Use of Antiidiotypic Antibodies as Vaccines Against Infectious Agents”, Critical Reviews in Immunology, vol. 7, Issue 4, 1987, pp. 269-284.
Wallich et al., “Evaluation of Genetic Divergence amongBorrelia burgdorferiIsolates by Use of OspA, fla, HSP60, and HSP70 Gene Probes”, Infection and Immunity, Nov. 1992, pp. 4856-4866.
Achtman et al., “A Comparison of the Variable Antigens Expressed by Clone IV-1 and Subgroup III ofNeisseria meningtidisSerogroup A”, The Journal of Infectious Diseases, 165:53-68 (1992).
LeFebvre et al., “Characterization ofBorrelia burgdorferiIsolates by Restriction Endonuclease Analysis and DNA Hybridization”, Journal of Clinical Microbiology, vol. 27, No. 4, pp. 636-639 (1989).
Postic et al., “Two Genomic Species inBorrella burgdorferi”, Res. Microbiol., 141, pp. 465-475 (1990).
Marconi et al., “Phylogenetic Analysis of the Gene Borrelia: a Comparison of North American and European Isolates ofBorrelia burgdorferi”, Journal of Bacteriology, vol. 174, No. 1, pp. 241-244 (1992).
Stalhammer-Carlemalm et al., “Plasmid Analysis and Restriction Fragment Length Polymorphisms of Chromosomal DNA Allo9w a Distinction BetweenBorrelia burgdorferiStrains”, Genetic Diversity ofBorrelia burgdorferi, 274: 28-39 (1990).
Adam et al., Phenotypic and Genotypic Analysis ofBorrelia burgdorferiIsolates from Various Sources, Infection and Immunity, vol. 59, No. 8, pp. 2579-2585 (1991).
Marconi et al., “Species-Specific Identification of and Distinction betweenBorrelia burgdorferiGenomic Groups by Using 16S rRNA-Directed Oligonucleotide Probes”, J. of Clincal Microbiology, vol. 30, No. 3, pp. 628-632 (1992).
Welsh et al., “Genomic Fingerprinting by Arbitrarily Primed Polymerase Chain Reaction ResolvesBorrelia burgdorferiinto Three Distinct Phyletic Groups”, International Journal of Systematic Bacteriology, vol. 42, No. 3, pp. 370-377 (1992).
Boerlin et al., “Population Genetic Analysis ofBorrelia burgdorferiIsolates ty Multilocus Enzyme Electrophoresis”, Infection and Immunity, vol. 60, No. 4, pp. 1677-1683 (1992).
Baranton et al., “Delineation ofBorrelia burgdorferiSensu Stricto,Borrelia gariniisp. nov., and Group VS461 Associated withy Lyme Borreliosis”, Intl. J. of Systematic Bacteriology, vol. 42, No. 3, pp. 378-383 (1992).
Marconi et al., “Transcriuptional Analyses and Mapping of the ospC Gene in Lyme Disease Spirochetes”, Journal of Bacteriology, vol. 175, No. 4, pp. 926-932 (1992).
Barbour et al., “Heterogeneity of Major Proteins in Lyme Disease Borreliae: A Molecular Analysis of North American and European Isolates”, Journal of Infectious Diseases, vol. 153, No. 3, pp. 478-484 (1985).
Fikrig et al., “Borrelia burgdorferiStrain 25015: Characterization of Outer Surface Protein A and Vaccination Against Infection”, Journal of Immunology, vol. 148, No. 7, pp. 2256-2260 (1992).
Wilske et al., Antigenic Variability ofBorrelia burgdorferi, Annals New York Academy of Sciences, pp. 127-143 (1988).
Fikrig et al., “Protection of Mice Against the Lyme Dis
Crowe Brian
Dorner Friedrich
Livey Ian
Baxter Vaccine AG
Heller Ehrman White & McAuliffe
Swartz Rodney P
LandOfFree
Immunogenic formulation of OspC antigen vaccines for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic formulation of OspC antigen vaccines for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic formulation of OspC antigen vaccines for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3403028